MACKENZIE FINANCIAL CORP - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$282,077
-16.1%
17,8530.0%0.00%
-100.0%
Q2 2023$336,172
+425.7%
17,853
+7.2%
0.00%
Q1 2023$63,948
-87.8%
16,653
-84.3%
0.00%
-100.0%
Q4 2022$525,279
+13.2%
105,903
+9.1%
0.00%0.0%
Q3 2022$464,000
+5.2%
97,035
-1.0%
0.00%0.0%
Q2 2022$441,000
+14.5%
98,037
+21.3%
0.00%0.0%
Q1 2022$385,000
-33.0%
80,816
+4.4%
0.00%0.0%
Q4 2021$575,000
+47.8%
77,446
+13.0%
0.00%0.0%
Q3 2021$389,000
-7.4%
68,530
+7.4%
0.00%0.0%
Q2 2021$420,000
-19.7%
63,796
-21.3%
0.00%0.0%
Q4 2020$523,00081,1100.00%
Other shareholders
IMMUNOGEN INC shareholders Q1 2022
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders